It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Human naïve pluripotent stem cells (hnPSCs) can generate integrated models of blastocysts termed blastoids upon switch to inductive medium. However, the underlying mechanisms remain obscure. Here we report that self-renewing hnPSCs spontaneously and efficiently give rise to blastoids upon three dimensional (3D) suspension culture. The spontaneous blastoids mimic early stage human blastocysts in terms of structure, size, and transcriptome characteristics and are capable of progressing to post-implantation stages. This property is conferred by the glycogen synthase kinase-3 (GSK3) signalling inhibitor IM-12 present in 5iLAF self-renewing medium. IM-12 upregulates oxidative phosphorylation-associated genes that underly the capacity of hnPSCs to generate blastoids spontaneously. Starting from day one of self-organization, hnPSCs at the boundary of all 3D aggregates dedifferentiate into E5 embryo-like intermediates. Intermediates co-express SOX2/OCT4 and GATA6 and by day 3 specify trophoblast fate, which coincides with cavity and blastoid formation. In summary, spontaneous blastoid formation results from 3D culture triggering dedifferentiation of hnPSCs into earlier embryo-like intermediates which are then competent to segregate blastocyst fates.
Blastoids are emerging models for early embryo development exploration in vitro. Here, authors found self-renewing human naïve PSCs spontaneously and efficiently give rise to blastoids upon three-dimensional suspension culture.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 Guangzhou Medical University, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072); Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China (GRID:grid.410737.6); Bioland Laboratory, Guangzhou International Bio Island, Guangzhou, China (GRID:grid.508040.9) (ISNI:0000 0004 9415 435X); The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072)
2 Guangzhou Medical University, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072); Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China (GRID:grid.410737.6); Bioland Laboratory, Guangzhou International Bio Island, Guangzhou, China (GRID:grid.508040.9) (ISNI:0000 0004 9415 435X)
3 Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China (GRID:grid.410737.6)
4 Guangzhou Medical University, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072); Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China (GRID:grid.410737.6)
5 Washington University School of Medicine, Department of Developmental Biology and Center of Regenerative Medicine, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
6 Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China (GRID:grid.4367.6)
7 Tongji University, Shanghai Key Laboratory of Maternal and Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Shanghai, China (GRID:grid.24516.34) (ISNI:0000000123704535)
8 Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China (GRID:grid.24516.34)